Health Care & Life Sciences » Pharmaceuticals | Apeloa Pharmaceutical Co. Ltd.

Apeloa Pharmaceutical Co. Ltd. A | Mutual Funds

Mutual Funds that own Apeloa Pharmaceutical Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
11,300,338
0.99%
11,300,338
3.81%
12/31/2017
GF Stable Growth Fund
9,600,000
0.84%
0
2.04%
12/31/2017
8,806,470
0.77%
8,806,470
3.46%
12/31/2017
Guotai Jinniu Innovation Growth Securities Investment Fund
7,500,000
0.65%
0
4.09%
12/31/2017
3,348,000
0.28%
2,665,874
3.59%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
1,977,321
0.17%
-382,529
0%
07/31/2018
1,230,500
0.11%
-18,344,138
0.62%
12/31/2017
843,440
0.07%
310,000
2.69%
12/31/2017
428,800
0.04%
50,100
0.33%
12/31/2017
Advisors Inner Circle - Acadian Emerging Markets Portfolio
409,100
0.04%
0
0.03%
07/31/2018

About Apeloa Pharmaceutical Co.

View Profile
Address
No. 333 Hengdianjiang South Road
Dongyang Zhejiang 322118
China
Employees -
Website http://www.apeloa.com
Updated 07/08/2019
Apeloa Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of active pharmaceutical ingredients, and drug preparation. Its products include levofloxacin hydrochloride, amantadine hydrochloride, ofloxacin, adamantane, and other pharmaceutical ingredients. It also offers capsules, ointment, granules, and injections.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.